findmyKOL
Clinical trialNCT05366881RecruitingObservational

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

SponsorAdela, IncEnrollment7,000Bladder CancerBrain CancerBreast CancerCervical CancerColorectal CancerEndometrial Cancer+14 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • City of Hope

    Duarte, California, United States

    Gregory Idos, MD
    Recruiting
  • Miami Cancer Institute

    Miami, Florida, United States

    Manmeet Ahluwalia, MD
    Recruiting
  • North Georgia Health System

    Gainesville, Georgia, United States

    Charles Nash, MD
    Recruiting
  • Baptist Floyd

    New Albany, Indiana, United States

    Amitoj Gill, MD
    Recruiting
  • Baptist Corbin

    Corbin, Kentucky, United States

    Abigail Byrnes, MD
    Recruiting
  • Baptist Hardin

    Elizabethtown, Kentucky, United States

    Christopher Burkeen, MD
    Recruiting
  • Baptist Lexington

    Lexington, Kentucky, United States

    Arvinda Padmanabhan, MD
    Recruiting
  • Baptist Paducah

    Paducah, Kentucky, United States

    Withdrawn
  • Allina Health Cancer Institute

    Minneapolis, Minnesota, United States

    Joleen Hubbard, MD
    Recruiting
  • Mayo Clinic

    Rochester, Minnesota, United States

    Lisa A Boardman, MD
    Recruiting
  • Cleveland Clinic

    Cleveland, Ohio, United States

    Peter Mazzone, MD, MPH
    Recruiting
  • Oregon Health Sciences University

    Portland, Oregon, United States

    Nima Nabavizadeh, MD
    Recruiting
  • Medical University of South Carolina

    Charleston, South Carolina, United States

    Gerard Silvestri, MD
    Recruiting
  • Mcleod Health

    Florence, South Carolina, United States

    Virginia Clyburn-Ipock, MD
    Recruiting
  • Baptist (bhmcc)

    Memphis, Tennessee, United States

    Philip Lammers, MD
    Recruiting
  • Vanderbilt-Ingram Cancer Center

    Nashville, Tennessee, United States

    Recruiting
  • Elligo Health Research, Inc.

    Austin, Texas, United States

    Faith Holmes, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
3 May 2022
Primary completion
31 Mar 2026
Completion
31 Mar 2027
Last update posted
20 Jan 2026
Registered enrollment
7,000
Registry id
NCT05366881

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.